AHR and triple-negative breast carcinoma: It was shown that AHR agonists TCDD and/or 3,3′-diindolylmethane and AHR inhibitors CH223191 [212] and CB7993113 [109] inhibited triple negative breast cancer invasion in vitro and metastasis in vivo.